Form 4: Boundless Bio Director, Nancy Whiting, Acquires Stock Options
SEC Form 4 Filing
Director Nancy Whiting acquired 13,219 stock options in Boundless Bio, Inc. on March 27, 2024, vesting monthly starting April 27, 2024.
Summary
- Nancy Whiting, a director of Boundless Bio, Inc., acquired 13,219 stock options on March 27, 2024.
- The options vest in 36 equal monthly installments beginning on April 27, 2024.
- The expiration date for the options is March 26, 2034.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to stock option grants, so the sentiment is neutral.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, such as directors, regarding the company's securities.
Stakeholder Impact
- The acquisition of stock options by a director can signal confidence in the company's future prospects to shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/27/2024 | Date of transaction: Nancy Whiting acquired stock options. |
| 04/27/2024 | First vesting date: Stock options vest in 36 substantially equal monthly installments beginning on this date. |
| 03/26/2034 | Expiration date: Stock options expire on this date. |
| 03/29/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.